MY ACCOUNT | NEWSLETTER |

Grant Avenue Capital Acquires 21st Century Healthcare


Grant Avenue Capital, LLC (“Grant Avenue”), a healthcare-focused, middle-market private equity firm, today announced the acquisition of 21st Century Healthcare, Inc. (“21st Century” or the “Company”), a leading provider of vitamins, minerals, and supplements (“VMS”) for both humans and pets. Terms of the transaction were not disclosed.

Founded in 1991, 21st Century manufactures and distributes a broad portfolio of VMS products across in-house brands – including Alaska Wild®, Arthri-Flex Advantage®, ImmuBlast®, Herbal Slimming Tea®, VitaJoy® and Zoo Friends® – as well as national brand equivalents and private label offerings. Guided by its mission to improve the health and well-being of individuals, families, and communities worldwide, 21st Century has demonstrated a strong track record of innovation while maintaining rigorous quality and safety standards.

Grant Avenue is partnering with Kirk Neal, 21st Century President and Chief Executive Officer, and his entire team of dedicated professionals, to build on the Company’s position as a trusted partner within the dietary supplements industry by expanding its product portfolio and scaling its operations. Grant Avenue Acceleration Partner Dave Meadows, former President of the Drug Substance Contract Development and Manufacturing Organization division at Cambrex, will join the 21st Century Board of Directors.

“This partnership marks an exciting new chapter for 21st Century and further validates our over 30-year commitment to quality and innovation,” said Mr. Neal. “Grant Avenue’s deep healthcare knowledge, industry network, and operational capabilities will enable us to strengthen our manufacturing footprint, broaden our product offerings, and enhance our contract manufacturing capabilities, while allowing our team to maintain the high quality, best-in-class service our customers expect and trust.”

Alex Ferree, Principal at Grant Avenue, added, “We see a compelling opportunity to build upon 21st Century’s strong momentum by expanding its market reach across both e-commerce and retail channels. As the Company continues to deepen its relationships with customers and partners, and deliver accessible, high-quality wellness products, we look forward to partnering with the 21st Century team to support its next phase of growth.”

Grant Avenue was advised by Lincoln International as lead debt advisor and McGuireWoods LLP as legal counsel.

About Grant Avenue Capital

Grant Avenue Capital is a healthcare-focused, middle-market private equity firm targeting investments alongside forward-thinking management teams that seek an experienced and innovative investor with operational insight and flexible capital to drive business growth. With decades of healthcare investing experience, deep industry knowledge, and a broad network of relationships, Grant Avenue actively supports the strategic and operational initiatives of its investments in pursuit of exceptional outcomes. Grant Avenue partners with companies in a variety of transaction structures, including founder recapitalizations, majority buyouts, minority investments, corporate carve-outs, and special situations. Grant Avenue is committed to delivering outstanding, risk-adjusted returns by actively building world-class companies that enhance patient health, strengthen the health system, and positively impact communities they serve. For more information, visit: https://grantave.com/

About 21st Century Healthcare

21st Century Healthcare is a leading manufacturer of vitamins and supplements dedicated to quality, innovation, and transparency. The Company’s state-of-the-art facilities in Tempe, Arizona, operate under strict Good Manufacturing Practices (GMP), supporting a broad portfolio of products for both humans and pets, including tablets, capsules, powders, and teas.


Source: www.21stcenturyvitamins.com

Like0
Dislike0
  • Please enter a comment


Name *
Email address *
Comment *


* Required fields

Information on the processing of your personal data
We inform you that, in compliance with the provisions of current national and European regulations for the Protection of Personal Data and Services of the Information Society and Electronic Commerce, by sending us this form you are expressly giving your consent to Grupo Asís Biomedia , SL, (hereinafter, "ASIS GROUP") so that, as the person in charge, it may process your personal data in order to respond to your request for contact and information by electronic means.

Likewise, when you expressly consent, we will process your personal data to send you specialized information, newsletters, offers and exclusive promotions from GRUPO ASIS and related companies.

For the aforementioned purpose, GRUPO ASIS may transfer your data to other companies linked to GRUPO ASIS or to third party service providers for the management of electronic communications and other security services, even in cases where they are outside of the European Union, provided that they legally guarantee the adequate level of protection required by European regulations.

At any time you can withdraw the consent given and exercise the rights of access, rectification, deletion, portability of your data and limitation or opposition to its treatment by contacting GRUPO ASIS by sending an email to protecciondatos @ grupoasis.com, or by written communication to address at Centro Empresarial El Trovador, 8th floor, office I, Plaza Antonio Beltrán Martínez 1, 50002, Zaragoza (Spain), indicating in either case the Ref. Personal data and the right you exercise, as well as attaching a copy of your ID or replacement identification document.


I have read and accept the treatment of my data according to the informed purpose and according Legal notes and the Privacy Policy
I wish to receive commercial information from GRUPO ASIS and related companies



More news

NC State Equine Surgeon Wins National Research Award for Work on Colic

Like0
Dislike0

Feline high-rise syndrome: a retrospective study on 42 cases

Like0
Dislike0

The association between serial point-of-care test results and hospitalization time in canine parvovirus infection (2003–2015)

Like0
Dislike0

Role of Secondary Plant Metabolites on Enteric Methane Mitigation in Ruminants

Like0
Dislike0

Grant to Treat Oncology Patients Saves Dog’s Leg

Like0
Dislike0

Newsletter

 
 

News of interest

EVENTS

Copyright © 2026 - All Rights Reserved
ISSN 2768-198X

Top